Status:
COMPLETED
Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
Lead Sponsor:
Sanwa Kagaku Kenkyusho Co., Ltd.
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.
Eligibility Criteria
Inclusion
- Type1 Diabetes
- Criteria of postprandial glucose and HbA1c are met
Exclusion
- Type2 Diabetes
- Patients with antidiabetic drugs
- The other exclusion criteria are met
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00213109
Last Update
September 21 2006
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Chiba, Japan
2
Fukuoka, Japan
3
Gifu, Japan
4
Ibaraki, Japan